Flemming L. Søndergaard

1.5k total citations
14 papers, 730 citations indexed

About

Flemming L. Søndergaard is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Flemming L. Søndergaard has authored 14 papers receiving a total of 730 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Endocrinology, Diabetes and Metabolism, 4 papers in Surgery and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Flemming L. Søndergaard's work include Diabetes Treatment and Management (11 papers), Diabetes Management and Research (8 papers) and Pancreatic function and diabetes (4 papers). Flemming L. Søndergaard is often cited by papers focused on Diabetes Treatment and Management (11 papers), Diabetes Management and Research (8 papers) and Pancreatic function and diabetes (4 papers). Flemming L. Søndergaard collaborates with scholars based in Denmark, Austria and India. Flemming L. Søndergaard's co-authors include Charlotte Granhall, Henrik Toft Sørensen, Mette S. Thomsen, John A. Baron, Lars Pedersen, Deirdre Cronin‐Fenton, Jon P. Fryzek, Karynsa Cetin, John Acquavella and Tine A. Bækdal and has published in prestigious journals such as British Journal of Cancer, Diabetologia and Clinical Pharmacokinetics.

In The Last Decade

Flemming L. Søndergaard

14 papers receiving 701 citations

Peers

Countries citing papers authored by Flemming L. Søndergaard

Since Specialization

Citations

This map shows the geographic impact of Flemming L. Søndergaard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Flemming L. Søndergaard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Flemming L. Søndergaard more than expected).

Fields of papers citing papers by Flemming L. Søndergaard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Flemming L. Søndergaard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Flemming L. Søndergaard. The network helps show where Flemming L. Søndergaard may publish in the future.

Co-authorship network of co-authors of Flemming L. Søndergaard

This figure shows the co-authorship network connecting the top 25 collaborators of Flemming L. Søndergaard. A scholar is included among the top collaborators of Flemming L. Søndergaard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Flemming L. Søndergaard. Flemming L. Søndergaard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	Absence of QTc Prolongation with Sodium N-(8-[2-Hydroxybenzoyl] Amino) Caprylate (SNAC), an Absorption Enhancer Co-Formulated with the GLP-1 Analogue Semaglutide for Oral Administration 2021 ·Diabetes Therapy ·Charlotte Granhall, Tine A. Bækdal, Astrid Breitschaft, Flemming L. Søndergaard, Thomas W. Anderson, Mette S. Thomsen	2
2	Effect of Various Dosing Conditions on the Pharmacokinetics of Oral Semaglutide, a Human Glucagon-Like Peptide-1 Analogue in a Tablet Formulation 2021 ·Diabetes Therapy ·Tine A. Bækdal, Astrid Breitschaft, Morten Donsmark, Stine Maarbjerg, Flemming L. Søndergaard, Jeanett Borregaard	28
3	Relationship Between Oral Semaglutide Tablet Erosion and Pharmacokinetics: A Pharmacoscintigraphic Study 2021 ·Clinical Pharmacology in Drug Development ·Tine A. Bækdal, Morten Donsmark, Marie‐Louise Hartoft‐Nielsen, Flemming L. Søndergaard, Alyson Connor	25
4	Safety and Pharmacokinetics of Single and Multiple Ascending Doses of the Novel Oral Human GLP-1 Analogue, Oral Semaglutide, in Healthy Subjects and Subjects with Type 2 Diabetes 2018 ·Clinical Pharmacokinetics ·Charlotte Granhall, Morten Donsmark, Thalia Marie Blicher, Georg Golor, Flemming L. Søndergaard, Mette S. Thomsen, Tine A. Bækdal	120
5	Pharmacokinetics, Safety and Tolerability of Oral Semaglutide in Subjects with Renal Impairment 2018 ·Clinical Pharmacokinetics ·Charlotte Granhall, Flemming L. Søndergaard, Mette S. Thomsen, Thomas W. Anderson	84
6	Insulin degludec's ultra-long pharmacokinetic properties observed in adults are retained in children and adolescents with type 1 diabetes 2014 ·Pediatric Diabetes ·Torben Biester, (unknown), K Remus, (unknown), Olga Kordonouri, Charlotte Granhall, Flemming L. Søndergaard, Niels Rode Kristensen, Hanne Haahr, Thomas Danne	41
7	Ultra-Long Pharmacokinetic Properties of Insulin Degludec are Comparable in Elderly Subjects and Younger Adults with Type 1 Diabetes Mellitus 2013 ·Drugs & Aging ·Stefan Korsatko, (unknown), Julia K. Mader, (unknown), Gerd Koehler, Gerlies Treiber, (unknown), Michael Wolf, (unknown), Flemming L. Søndergaard, Hanne Haahr, Thomas R. Pieber	27
8	Antidiabetic treatments and risk of hospitalisation with myocardial infarction: a nationwide case–control study 2011 ·Pharmacoepidemiology and Drug Safety ·Henriette Thisted Horsdal, Flemming L. Søndergaard, Søren Paaske Johnsen, Jørgen Rungby	20
9	Initiation with once-daily BIAsp 30 results in superior outcome compared to insulin glargine in Asians with type 2 diabetes inadequately controlled by oral anti-diabetic drugs 2010 ·Diabetes Research and Clinical Practice ·(unknown), (unknown), (unknown), (unknown), Flemming L. Søndergaard, Plamen Kozlovski, Wan Mohamad Wan Bebakar	24
10	Hospitalisation for venous thromboembolism in cancer patients and the general population: a population-based cohort study in Denmark, 1997–2006 2010 ·British Journal of Cancer ·Deirdre Cronin‐Fenton, Flemming L. Søndergaard, Lars Pedersen, Jon P. Fryzek, Karynsa Cetin, John Acquavella, John A. Baron, Henrik Toft Sørensen	289
11	Sulfonylureas and prognosis after myocardial infarction in patients with diabetes: a population‐based follow‐up study 2009 ·Diabetes/Metabolism Research and Reviews ·Henriette Thisted Horsdal, Søren Paaske Johnsen, Flemming L. Søndergaard, Jacob Jacobsen, Reimar W. Thomsen, Ole Schmitz, Henrik Toft Sørensen, Jørgen Rungby	33
12	Use of aprotinin in cardiac surgery: effectiveness and safety in a population-based study☆ 2009 ·European Journal of Cardio-Thoracic Surgery ·Carl-Johan Jakobsen, Flemming L. Søndergaard, Vibeke E. Hjortdal, Søren Paaske Johnsen	14
13	Type of preadmission glucose-lowering treatment and prognosis among patients hospitalised with myocardial infarction: a nationwide follow-up study 2008 ·Diabetologia ·Henriette Thisted Horsdal, Søren Paaske Johnsen, Flemming L. Søndergaard, Jørgen Rungby	22
14	OC-03 A population-based cohort study of the incidence of venous thromboembolism in Danish cancer patients compared to the general population 2007 ·Thrombosis Research ·Deirdre Cronin‐Fenton, Flemming L. Søndergaard, Lars Møller Pedersen, Jon P. Fryzek, Karynsa Cetin, John Acquavella, Henrik Toft Sørensen	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact